Results 31 to 40 of about 52,004 (230)

Porcine circovirus 2: Status atual e seus desafios

open access: yesPubvet, 2022
Os circovírus suíno (Porcine circovirus - PCV), descritos pela primeira vez na década de 70, são os menores vírus pertencentes à família Circoviridae.
Rosecleer Rodrigues da Silva   +1 more
doaj   +1 more source

A Bivalent Recombinant Mycobacterium bovis BCG Expressing the S1 Subunit of the Pertussis Toxin Induces a Polyfunctional CD4+ T Cell Immune Response

open access: yesBioMed Research International, Volume 2019, Issue 1, 2019., 2019
Background. A recombinant BCG strain expressing the genetically detoxified S1 subunit of pertussis toxin 9K/129G (rBCG‐S1PT), previously constructed by our research group, demonstrated the ability to develop high protection in mouse models of pertussis challenge which correlated with the induction of a Th1 immune response pattern.
Alex I. Kanno   +5 more
wiley   +1 more source

Optimization of methods for isolation and purification of outer membrane vesicles (OMVs) from Neisseria lactamica

open access: yesApplied Microbiology and Biotechnology
Outer membrane vesicles (OMVs) are nanoparticles released by Gram-negative bacteria during growth, mainly under stress conditions. OMV-based vaccines have played an important role in vaccination against Neisseria meningitidis serogroup B (MenB ...
Ronaldo Moraes Preto   +6 more
doaj   +1 more source

Evaluation of Lsa46 and Lsa77 Leptospiral Proteins for Their Immunoprotective Activities in Hamster Model of Leptospirosis

open access: yesBioMed Research International, Volume 2018, Issue 1, 2018., 2018
Leptospirosis is a neglected tropical disease caused by pathogenic Leptospira spp. The lack of an effective vaccine favors the increase of the disease. Currently, surface‐exposed proteins are the main targets for the search of vaccine candidates. In this study, we examined whether the surface Lsa46 and Lsa77 proteins, previously identified as laminin ...
Aline F. Teixeira   +7 more
wiley   +1 more source

The immunogenic potential of an optimized mRNA lipid nanoparticle formulation carrying sequences from virus and protozoan antigens

open access: yesJournal of Nanobiotechnology
Background Lipid nanoparticles (LNP) are a safe and effective messenger RNA (mRNA) delivery system for vaccine applications, as shown by the COVID-19 mRNA vaccines.
Renata S. Fernandes   +13 more
doaj   +1 more source

Seroprevalence study reveals pertussis underreporting in Brazil and calls for adolescent/young adult boosting: mouse model demonstrates immunity restoration

open access: yesFrontiers in Immunology
BackgroundPertussis continues to pose a significant threat despite the availability of effective vaccines. The challenge lies in the vulnerability of infants who have not yet completed their vaccination schedule and in adolescents and adults becoming ...
Eliane P. Silva   +14 more
doaj   +1 more source

In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment

open access: yesFrontiers in Immunology, 2019
The live attenuated mycobacterial strain BCG, in use as vaccine against tuberculosis, is considered the gold standard for primary therapy of carcinoma in situ of the bladder.
Dunia Rodriguez   +12 more
doaj   +1 more source

A diplomacia das vacinas

open access: yesGV-EXECUTIVO, 2021
A Índia desponta como força global para ajudar a imunizar populações em países em desenvolvimento contra a Covid-19 e tem sido um dos principais fornecedores de insumos para o Brasil.
Guilherme Casarões   +1 more
openaire   +1 more source

Efficacy of Der f 2/Zen 1‐LAMP1 Plasmid‐Based Vaccine Immunotherapy in Dogs With Atopic Dermatitis: A Proof‐of‐Concept Study

open access: yesVeterinary Dermatology, Volume 37, Issue 2, Page 306-318, April 2026.
Background: DNA‐based vaccination rapidly induces strong cellular and humoral immune responses, which may be enhanced by inclusion of lysosomal‐associated membrane protein‐1 (LAMP). Objectives: This proof‐of‐concept study evaluated the efficacy and safety of a Der f 2/Zen 1‐LAMP‐based DNA vaccine immunotherapy in client‐owned dogs with nonseasonal AD ...
Petra Bizikova   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy